- Home
- EVAX vs CSCI Comparison
EVAX vs CSCI Comparison
Compare EVAX & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- CSCI
- Stock Information
- Founded
- EVAX 2008
- CSCI 1990
- Country
- EVAX Denmark
- CSCI Canada
- Employees
- EVAX N/A
- CSCI N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- CSCI
- Sector
- EVAX Health Care
- CSCI
- Exchange
- EVAX Nasdaq
- CSCI NYSE
- Market Cap
- EVAX 10.8M
- CSCI 10.5M
- IPO Year
- EVAX 2021
- CSCI 1996
- Fundamental
- Price
- EVAX $3.13
- CSCI $3.61
- Analyst Decision
- EVAX Strong Buy
- CSCI
- Analyst Count
- EVAX 2
- CSCI 0
- Target Price
- EVAX $10.00
- CSCI N/A
- AVG Volume (30 Days)
- EVAX 134.8K
- CSCI 3.3K
- Earning Date
- EVAX 05-27-2025
- CSCI 05-13-2025
- Dividend Yield
- EVAX N/A
- CSCI N/A
- EPS Growth
- EVAX N/A
- CSCI N/A
- EPS
- EVAX N/A
- CSCI N/A
- Revenue
- EVAX $3,293,000.00
- CSCI $9,030,000.00
- Revenue This Year
- EVAX N/A
- CSCI N/A
- Revenue Next Year
- EVAX N/A
- CSCI N/A
- P/E Ratio
- EVAX N/A
- CSCI N/A
- Revenue Growth
- EVAX 2555.64
- CSCI 36.51
- 52 Week Low
- EVAX $1.20
- CSCI $1.96
- 52 Week High
- EVAX $19.95
- CSCI $7.72
- Technical
- Relative Strength Index (RSI)
- EVAX 75.25
- CSCI N/A
- Support Level
- EVAX $2.58
- CSCI N/A
- Resistance Level
- EVAX $2.84
- CSCI N/A
- Average True Range (ATR)
- EVAX 0.25
- CSCI 0.00
- MACD
- EVAX 0.10
- CSCI 0.00
- Stochastic Oscillator
- EVAX 96.79
- CSCI 0.00
About EVAX Evaxion Biotech
Evaxion AS is in the field of oncology. It used the AI-Immunology platform.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.